Bio-Rad Laboratories Class A
482 hedge funds and large institutions have $6.06B invested in Bio-Rad Laboratories Class A in 2023 Q4 according to their latest regulatory filings, with 87 funds opening new positions, 164 increasing their positions, 171 reducing their positions, and 64 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
0.2% less ownership
Funds ownership: 78.26% → 78.05% (-0.2%)
4% less repeat investments, than reductions
Existing positions increased: 164 | Existing positions reduced: 171
10% less capital invested
Capital invested by funds: $6.73B → $6.06B (-$668M)
Holders
482
Holding in Top 10
10
Calls
$47.3M
Puts
$28.5M
Top Buyers
| 1 | +$92.4M | |
| 2 | +$61.9M | |
| 3 | +$54.6M | |
| 4 |
SHCM
Sachem Head Capital Management
New York
|
+$50.6M |
| 5 |
Select Equity Group
New York
|
+$43.5M |
Top Sellers
| 1 | -$304M | |
| 2 | -$76.8M | |
| 3 | -$49.5M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$38.5M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
-$37.2M |